Skip to content

Clinical trials

Observational Stomach Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Observational Clear all

756 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20011
20027
20033
20045
20057
20066
200712
20089
200911
201029
201116
201225
201329
201417
201521
201637
201741
201829
201946
202044
202158
202257
202363
202472
202551
202645

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed278
Unknown status220
Recruiting152
Not yet recruiting37
Active, not recruiting30
Terminated18
Enrolling by invitation12
Withdrawn7
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fujian Medical University19
National Cancer Institute (NCI)14
Yonsei University13
Shanghai Zhongshan Hospital12
Peking University11
Fudan University10
Seoul National University Bundang Hospital10
Memorial Sloan Kettering Cancer Center9
Nanfang Hospital, Southern Medical University9
Tianjin Medical University Cancer Institute and Hospital9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms756
Esophageal Neoplasms113
Pancreatic Neoplasms93
Colorectal Neoplasms81
Breast Neoplasms59
Lung Neoplasms56
Neoplasms48
Colonic Neoplasms44
Liver Neoplasms44
Ovarian Neoplasms36

Trials

Showing 26 to 50 of 756. Each trial links to its page on Pharma Observatory.

656 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.